+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Radiopharmaceuticals in Nuclear Medicine Market - Global Forecast 2025-2030- Product Image
Radiopharmaceuticals in Nuclear Medicine Market - Global Forecast 2025-2030- Product Image
Sale

Radiopharmaceuticals in Nuclear Medicine Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 198 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6127154
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Radiopharmaceuticals are transforming the global nuclear medicine landscape by enabling clinicians to combine molecular imaging with targeted therapies, driving innovation in diagnostics and personalized care. This report provides senior decision-makers with a comprehensive analysis of market segmentation, regulatory shifts, competition, and strategic recommendations essential for navigating sustained industry growth.

Market Snapshot: Radiopharmaceuticals Market Growth and Dynamics

The radiopharmaceuticals market is experiencing robust expansion, shaped by advances in synthesis methods, increased clinical adoption, and streamlined regulatory processes. A strong pipeline of diagnostic and therapeutic agents fueled by investment in PET and SPECT modalities, along with new regulatory incentives, positions the sector for ongoing momentum. Key geographic territories across the Americas, EMEA, and Asia-Pacific are influencing manufacturing, supply chain, and distribution strategies, as competitive pressures accelerate the development of novel theranostic solutions and market-entry pathways.

Scope & Segmentation: Detailed Analysis of Radiopharmaceuticals Market

  • Product Types: Diagnostic radiopharmaceuticals (including PET and SPECT agents such as fluorine-18, gallium-68, iodine-123, and technetium-99m) and therapeutic agents (alpha emitters like actinium-225, radium-223, and beta emitters such as iodine-131, lutetium-177, and yttrium-90).
  • Applications: Brain imaging (utilizing PET and SPECT brain agents), cardiology (featuring Tc-99m perfusion tracers and fluorine-18 viability agents), oncology (covering PET imaging, technetium-99m diagnostics, and alpha/beta emitter therapies).
  • Radionuclide Focus: Analysis of main clinical isotopes: fluorine-18, iodine-131, lutetium-177, technetium-99m, and yttrium-90.
  • End Users: Targeted at academic research institutes, hospitals and clinics (private and public), and imaging centers (diagnostic imaging and specialty therapy).
  • Distribution Channels: Includes both direct sales and indirect sales channels, comprising distributors and wholesalers (national and regional), with emphasis on cold-chain management.
  • Regional Coverage: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, South Africa, and others), and Asia-Pacific (such as China, India, Japan, Australia, South Korea, Indonesia, and more).
  • Key Market Participants: Major players feature Cardinal Health, General Electric Company, Lantheus Holdings, Curium Pharma, Jubilant Radiopharma Services, Bracco Imaging, Novartis, Eckert & Ziegler, Ion Beam Applications, and Nordion.

Key Takeaways for Senior Decision-Makers

  • Theranostic integration is shifting nuclear medicine toward personalized diagnostics and treatment planning, presenting new value opportunities for healthcare providers and industry stakeholders.
  • Market segmentation reveals a dual focus on diagnostic excellence (PET and SPECT agents) and precision-targeted therapies leveraging alpha and beta emitters.
  • Collaborative innovation across academic, manufacturing, and clinical channels is reducing time-to-market for novel agents while supporting robust data-driven outcomes assessment.
  • Regulatory adaptation and harmonized global approval pathways are catalyzing product launches and expanding patient access through regional investment and infrastructure development.
  • Digital transformation, from automated synthesis modules to AI-powered imaging analytics, is enhancing clinical confidence and operational efficiency throughout the radiopharmaceutical value chain.

Tariff Impact: Navigating U.S. Trade Policy Effects

The introduction of 2025 United States tariffs on radiopharmaceutical components is impacting supply chains, leading to cost increases for raw materials and reagents. Providers may experience pressure on margins and adjustments in procurement, with resultant shifts in sourcing strategies. Efforts to ramp up domestic production and realign regional manufacturing are underway, although transitional phases may introduce temporary supply constraints. These policies are prompting innovation, vertical integration, and new partnerships to optimize costs, regulatory compliance, and patient access.

Methodology & Data Sources

This report draws on interviews with clinical directors, radiochemists, regulatory professionals, and supply chain executives. Complementary research includes reviews of scientific journals, regulatory filings, patent repositories, clinical trial databases, and industry white papers. Rigorous quality checks, stakeholder workshops, and expert panel reviews underpin the analysis, ensuring actionable insights throughout.

Why This Report Matters

  • Provides executive-level clarity on evolving radiopharmaceutical market dynamics, supporting informed capital allocation and strategic planning.
  • Identifies actionable recommendations to enhance supply chain resilience, accelerate clinical innovation, and align product offerings with the needs of diverse healthcare environments.

Conclusion

The radiopharmaceuticals market is defined by rapid technological, regulatory, and clinical evolution. Leaders leveraging this analysis are equipped to capture emerging opportunities, drive innovation, and deliver sustainable value across the nuclear medicine ecosystem.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Surge in global adoption of gallium-68 PSMA agents for advanced prostate cancer imaging
5.2. Emergence of alpha-emitter radiopharmaceuticals such as actinium-225 therapies for targeted cancer approach
5.3. Integration of artificial intelligence in radiopharmaceutical development to optimize tracer design and dosimetry
5.4. Growing investments in cold kit technologies enabling in-house technetium-99m radiotracer formulation
5.5. Regulatory acceleration of novel PET tracers under FDA breakthrough therapy designation pathways
5.6. Expansion of supply chain resilience measures to mitigate molybdenum-99 shortages and generator constraints
5.7. Partnership-driven manufacturing scale-up of lutetium-177 conjugates to meet rising theranostic demands
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Radiopharmaceuticals in Nuclear Medicine Market, by Product Type
8.1. Introduction
8.2. Diagnostic Radiopharmaceuticals
8.2.1. PET
8.2.1.1. Fluorine-18 Radiopharmaceuticals
8.2.1.2. Gallium-68 Radiopharmaceuticals
8.2.2. SPECT
8.2.2.1. Iodine-123 Radiopharmaceuticals
8.2.2.2. Technetium-99m Radiopharmaceuticals
8.3. Therapeutic Radiopharmaceuticals
8.3.1. Alpha Emitter
8.3.1.1. Actinium-225
8.3.1.2. Radium-223
8.3.2. Beta Emitter
8.3.2.1. Iodine-131
8.3.2.2. Lutetium-177
8.3.2.3. Yttrium-90
9. Radiopharmaceuticals in Nuclear Medicine Market, by Application
9.1. Introduction
9.2. Brain Imaging
9.2.1. PET Brain Agents
9.2.2. SPECT Brain Agents
9.3. Cardiology
9.3.1. Perfusion Imaging
9.3.1.1. Tc-99m Perfusion Agents
9.3.2. Viability Imaging
9.3.2.1. Fluorine-18 Viability Agents
9.4. Oncology
9.4.1. PET Imaging
9.4.1.1. Fluorine-18 Radiopharmaceuticals
9.4.1.2. Technetium-99m Radiopharmaceuticals
9.4.2. Therapy
9.4.2.1. Alpha Emitter Therapy
9.4.2.1.1. Actinium-225
9.4.2.2. Beta Emitter Therapy
9.4.2.2.1. Lutetium-177
10. Radiopharmaceuticals in Nuclear Medicine Market, by Radionuclide
10.1. Introduction
10.2. Fluorine-18
10.3. Iodine-131
10.4. Lutetium-177
10.5. Technetium-99m
10.6. Yttrium-90
11. Radiopharmaceuticals in Nuclear Medicine Market, by End User
11.1. Introduction
11.2. Academic & Research Institutes
11.3. Hospitals & Clinics
11.3.1. Private Clinics
11.3.2. Public Hospitals
11.4. Imaging Centers
11.4.1. Diagnostic Imaging Centers
11.4.2. Specialty Therapy Centers
12. Radiopharmaceuticals in Nuclear Medicine Market, by Distribution Channel
12.1. Introduction
12.2. Direct Sales
12.3. Indirect Sales
12.3.1. Distributors
12.3.2. Wholesalers
12.3.2.1. National Wholesalers
12.3.2.2. Regional Wholesalers
13. Americas Radiopharmaceuticals in Nuclear Medicine Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Cardinal Health, Inc.
16.3.2. General Electric Company
16.3.3. Lantheus Holdings, Inc.
16.3.4. Curium Pharma
16.3.5. Jubilant Radiopharma Services Inc.
16.3.6. Bracco Imaging S.p.A.
16.3.7. Novartis AG
16.3.8. Eckert & Ziegler Strahlen- und Medizintechnik AG
16.3.9. Ion Beam Applications S.A.
16.3.10. Nordion Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY RADIONUCLIDE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY RADIONUCLIDE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET: RESEARCHAI
FIGURE 26. RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET: RESEARCHSTATISTICS
FIGURE 27. RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET: RESEARCHCONTACTS
FIGURE 28. RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PET, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PET, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY FLUORINE-18 RADIOPHARMACEUTICALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY FLUORINE-18 RADIOPHARMACEUTICALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY GALLIUM-68 RADIOPHARMACEUTICALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY GALLIUM-68 RADIOPHARMACEUTICALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PET, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY SPECT, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY SPECT, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY IODINE-123 RADIOPHARMACEUTICALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY IODINE-123 RADIOPHARMACEUTICALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY TECHNETIUM-99M RADIOPHARMACEUTICALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY TECHNETIUM-99M RADIOPHARMACEUTICALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTER, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTER, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY ACTINIUM-225, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY ACTINIUM-225, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY RADIUM-223, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY RADIUM-223, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTER, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTER, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTER, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTER, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY IODINE-131, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY IODINE-131, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY LUTETIUM-177, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY LUTETIUM-177, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY YTTRIUM-90, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY YTTRIUM-90, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTER, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTER, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY BRAIN IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY BRAIN IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PET BRAIN AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PET BRAIN AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY SPECT BRAIN AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY SPECT BRAIN AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY BRAIN IMAGING, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY BRAIN IMAGING, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY CARDIOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PERFUSION IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PERFUSION IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY TC-99M PERFUSION AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY TC-99M PERFUSION AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PERFUSION IMAGING, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PERFUSION IMAGING, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY VIABILITY IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY VIABILITY IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY FLUORINE-18 VIABILITY AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY FLUORINE-18 VIABILITY AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY VIABILITY IMAGING, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY VIABILITY IMAGING, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY CARDIOLOGY, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY CARDIOLOGY, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PET IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PET IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY FLUORINE-18 RADIOPHARMACEUTICALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY FLUORINE-18 RADIOPHARMACEUTICALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY TECHNETIUM-99M RADIOPHARMACEUTICALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY TECHNETIUM-99M RADIOPHARMACEUTICALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PET IMAGING, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PET IMAGING, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTER THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTER THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY ACTINIUM-225, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY ACTINIUM-225, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTER THERAPY, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTER THERAPY, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTER THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTER THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY LUTETIUM-177, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY LUTETIUM-177, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTER THERAPY, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTER THERAPY, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY THERAPY, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY THERAPY, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY RADIONUCLIDE, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY RADIONUCLIDE, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY FLUORINE-18, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY FLUORINE-18, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY IODINE-131, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY IODINE-131, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY LUTETIUM-177, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY LUTETIUM-177, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY TECHNETIUM-99M, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY TECHNETIUM-99M, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY YTTRIUM-90, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY YTTRIUM-90, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PRIVATE CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PRIVATE CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY IMAGING CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY IMAGING CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY SPECIALTY THERAPY CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY SPECIALTY THERAPY CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 137. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY IMAGING CENTERS, 2018-2024 (USD MILLION)
TABLE 138. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY IMAGING CENTERS, 2025-2030 (USD MILLION)
TABLE 139. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 140. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 141. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 142. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 143. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY INDIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 144. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY INDIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 145. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 146. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 147. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY WHOLESALERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 148. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY WHOLESALERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 149. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY NATIONAL WHOLESALERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 150. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY NATIONAL WHOLESALERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 151. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY REGIONAL WHOLESALERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 152. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY REGIONAL WHOLESALERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 153. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY WHOLESALERS, 2018-2024 (USD MILLION)
TABLE 154. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY WHOLESALERS, 2025-2030 (USD MILLION)
TABLE 155. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY INDIRECT SALES, 2018-2024 (USD MILLION)
TABLE 156. GLOBAL RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY INDIRECT SALES, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 161. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2024 (USD MILLION)
TABLE 162. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PET, 2025-2030 (USD MILLION)
TABLE 163. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2024 (USD MILLION)
TABLE 164. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2025-2030 (USD MILLION)
TABLE 165. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 166. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 167. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTER, 2018-2024 (USD MILLION)
TABLE 168. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTER, 2025-2030 (USD MILLION)
TABLE 169. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTER, 2018-2024 (USD MILLION)
TABLE 170. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTER, 2025-2030 (USD MILLION)
TABLE 171. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 172. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 173. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY BRAIN IMAGING, 2018-2024 (USD MILLION)
TABLE 174. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY BRAIN IMAGING, 2025-2030 (USD MILLION)
TABLE 175. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY CARDIOLOGY, 2018-2024 (USD MILLION)
TABLE 176. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY CARDIOLOGY, 2025-2030 (USD MILLION)
TABLE 177. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PERFUSION IMAGING, 2018-2024 (USD MILLION)
TABLE 178. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PERFUSION IMAGING, 2025-2030 (USD MILLION)
TABLE 179. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY VIABILITY IMAGING, 2018-2024 (USD MILLION)
TABLE 180. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY VIABILITY IMAGING, 2025-2030 (USD MILLION)
TABLE 181. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 182. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 183. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PET IMAGING, 2018-2024 (USD MILLION)
TABLE 184. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PET IMAGING, 2025-2030 (USD MILLION)
TABLE 185. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY THERAPY, 2018-2024 (USD MILLION)
TABLE 186. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY THERAPY, 2025-2030 (USD MILLION)
TABLE 187. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTER THERAPY, 2018-2024 (USD MILLION)
TABLE 188. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTER THERAPY, 2025-2030 (USD MILLION)
TABLE 189. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTER THERAPY, 2018-2024 (USD MILLION)
TABLE 190. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTER THERAPY, 2025-2030 (USD MILLION)
TABLE 191. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY RADIONUCLIDE, 2018-2024 (USD MILLION)
TABLE 192. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY RADIONUCLIDE, 2025-2030 (USD MILLION)
TABLE 193. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 194. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 195. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
TABLE 196. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
TABLE 197. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY IMAGING CENTERS, 2018-2024 (USD MILLION)
TABLE 198. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY IMAGING CENTERS, 2025-2030 (USD MILLION)
TABLE 199. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 200. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 201. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY INDIRECT SALES, 2018-2024 (USD MILLION)
TABLE 202. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY INDIRECT SALES, 2025-2030 (USD MILLION)
TABLE 203. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY WHOLESALERS, 2018-2024 (USD MILLION)
TABLE 204. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY WHOLESALERS, 2025-2030 (USD MILLION)
TABLE 205. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 206. AMERICAS RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 207. UNITED STATES RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 208. UNITED STATES RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 209. UNITED STATES RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 210. UNITED STATES RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 211. UNITED STATES RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2024 (USD MILLION)
TABLE 212. UNITED STATES RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PET, 2025-2030 (USD MILLION)
TABLE 213. UNITED STATES RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2024 (USD MILLION)
TABLE 214. UNITED STATES RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2025-2030 (USD MILLION)
TABLE 215. UNITED STATES RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 216. UNITED STATES RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 217. UNITED STATES RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTER, 2018-2024 (USD MILLION)
TABLE 218. UNITED STATES RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTER, 2025-2030 (USD MILLION)
TABLE 219. UNITED STATES RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTER, 2018-2024 (USD MILLION)
TABLE 220. UNITED STATES RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTER, 2025-2030 (USD MILLION)
TABLE 221. UNITED STATES RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 222. UNITED STATES RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 223. UNITED STATES RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY BRAIN IMAGING, 2018-2024 (USD MILLION)
TABLE 224. UNITED STATES RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY BRAIN IMAGING, 2025-2030 (USD MILLION)
TABLE 225. UNITED STATES RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY CARDIOLOGY, 2018-2024 (USD MILLION)
TABLE 226. UNITED STATES RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY CARDIOLOGY, 2025-2030 (USD MILLION)
TABLE 227. UNITED STATES RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PERFUSION IMAGING, 2018-2024 (USD MILLION)
TABLE 228. UNITED STATES RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PERFUSION IMAGING, 2025-2030 (USD MILLION)
TABLE 229. UNITED STATES RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY VIABILITY IMAGING, 2018-2024 (USD MILLION)
TABLE 230. UNITED STATES RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY VIABILITY IMAGING, 2025-2030 (USD MILLION)
TABLE 231. UNITED STATES RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 232. UNITED STATES RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 233. UNITED STATES RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PET IMAGING, 2018-2024 (USD MILLION)
TABLE 234. UNITED STATES RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PET IMAGING, 2025-2030 (USD MILLION)
TABLE 235. UNITED STATES RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY THERAPY, 2018-2024 (USD MILLION)
TABLE 236. UNITED STATES RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY THERAPY, 2025-2030 (USD MILLION)
TABLE 237. UNITED STATES RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTER THERAPY, 2018-2024 (USD MILLION)
TABLE 238. UNITED STATES RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTER THERAPY, 2025-2030 (USD MILLION)
TABLE 239. UNITED STATES RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTER THERAPY, 2018-2024 (USD MILLION)
TABLE 240. UNITED STATES RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTER THERAPY, 2025-2030 (USD MILLION)
TABLE 241. UNITED STATES RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY RADIONUCLIDE, 2018-2024 (USD MILLION)
TABLE 242. UNITED STATES RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY RADIONUCLIDE, 2025-2030 (USD MILLION)
TABLE 243. UNITED STATES RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 244. UNITED STATES RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 245. UNITED STATES RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
TABLE 246. UNITED STATES RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
TABLE 247. UNITED STATES RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY IMAGING CENTERS, 2018-2024 (USD MILLION)
TABLE 248. UNITED STATES RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY IMAGING CENTERS, 2025-2030 (USD MILLION)
TABLE 249. UNITED STATES RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 250. UNITED STATES RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 251. UNITED STATES RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY INDIRECT SALES, 2018-2024 (USD MILLION)
TABLE 252. UNITED STATES RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY INDIRECT SALES, 2025-2030 (USD MILLION)
TABLE 253. UNITED STATES RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY WHOLESALERS, 2018-2024 (USD MILLION)
TABLE 254. UNITED STATES RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY WHOLESALERS, 2025-2030 (USD MILLION)
TABLE 255. UNITED STATES RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 256. UNITED STATES RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 257. CANADA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 258. CANADA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 259. CANADA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 260. CANADA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY DIAGNOSTIC RADIOPHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 261. CANADA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PET, 2018-2024 (USD MILLION)
TABLE 262. CANADA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY PET, 2025-2030 (USD MILLION)
TABLE 263. CANADA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2018-2024 (USD MILLION)
TABLE 264. CANADA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY SPECT, 2025-2030 (USD MILLION)
TABLE 265. CANADA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 266. CANADA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY THERAPEUTIC RADIOPHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 267. CANADA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTER, 2018-2024 (USD MILLION)
TABLE 268. CANADA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY ALPHA EMITTER, 2025-2030 (USD MILLION)
TABLE 269. CANADA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTER, 2018-2024 (USD MILLION)
TABLE 270. CANADA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET SIZE, BY BETA EMITTER, 2025-2030 (USD MILLION)
TABLE 271. CANADA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Radiopharmaceuticals in Nuclear Medicine market report include:
  • Cardinal Health, Inc.
  • General Electric Company
  • Lantheus Holdings, Inc.
  • Curium Pharma
  • Jubilant Radiopharma Services Inc.
  • Bracco Imaging S.p.A.
  • Novartis AG
  • Eckert & Ziegler Strahlen- und Medizintechnik AG
  • Ion Beam Applications S.A.
  • Nordion Inc.

Related Topics

Related Reports

Nuclear Medicine & Radiopharmaceuticals Market - Global Forecast 2025-2030 - Product Image

Nuclear Medicine & Radiopharmaceuticals Market - Global Forecast 2025-2030

  • Report
  • 194 Pages
  • Global
From
Radiopharmaceutical for Nuclear Medicine Market - Global Forecast 2025-2030 - Product Image

Radiopharmaceutical for Nuclear Medicine Market - Global Forecast 2025-2030

  • Report
  • 189 Pages
  • Global
From
Radiopharmaceuticals Market - Products and Applications - Product Image

Radiopharmaceuticals Market - Products and Applications

  • Report
  • 307 Pages
  • Global
From
Nuclear Medicine Market Report and Forecast 2025-2034 - Product Image

Nuclear Medicine Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From
Radiopharmaceuticals Market Growth Analysis Report - Market Size, Share, Forecast Trends and Outlook (2025-2034) - Product Image

Radiopharmaceuticals Market Growth Analysis Report - Market Size, Share, Forecast Trends and Outlook (2025-2034)

  • Report
  • 400 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.